843.347.2450
Appointments
843.347.8600
Billing (Press 1)
Telehealth

843.347.2450

Appointments

843.347.8600

Billing Questions (Press 1)

Payments

Pay Your BIll Online

Telehealth

Connect via Telehealth

Dr. Neal Shore

MD, FACS

Carolina Urologic Research Center
Myrtle Beach, South Carolina

BIO

Dr. Neal Shore graduated from Duke University and Duke University Medical School. He completed his general surgery/urology residency at New York Hospital-Cornell Medical Center/Memorial Sloan Kettering Cancer Center. He serves as the Medical Director for the Carolina Urologic Research Center.

Dr. Shore has conducted more than 400 clinical trials, focusing mainly on genitourinary oncology, and has authored more than 350 peer-reviewed publications and numerous book chapters. He serves on the Society for Immunotherapy of Cancer (SITC) Guidelines Committee for Bladder Cancer, as well as the boards of the Bladder Cancer Advocacy Network, the APCCC Scientific Steering Committee, Maple Tree Cancer Alliance, Alessa Therapeutics, Photocure, and the Duke Global Health Institute. He is the Chair of both the Prostate Cancer Academy and the Bladder/Kidney Cancer Academy, and was the co-chair of the annual AUA International Prostate Forum for 10 years. He has served/serves on the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE, Urology Practice, JUOP, Everyday Urology Oncology, and World Journal of Urology. He is the Editor-in-Chief of Reviews in Urology. He is a Fellow of the American College of Surgeons and a Certified Physician Investigator.

EDUCATION
Duke University – BA, Public Policy Sciences, Durham, NC 1980
Duke University School of Medicine – MD, Durham, NC 1984

RESIDENCIES

The New York Hospital-Cornell Medical Center
Urology: July 1986 – July 1990
Chief Resident: July 1989-1990
General Surgery: July 1984 – July 1986
Residency included a 6-month surgical rotation at Memorial Sloan-Kettering Cancer Center

BOARD CERTIFICATIONS
Board Certified – Urology
Fellow of the American College of Surgeons

CLINICAL EXPERTISE

Urology
Urologic Surgery

SPECIAL INTERESTS
Internationally recognized expert/researcher in systemic therapies for patients with advanced Urologic Cancers: Prostate, Kidney, and Bladder.
Internationally recognized expert/researcher for innovative therapies to treat patients suffering from prostate enlargement symptoms.

GOVERNMENT BOARDS

Genitourinary Cancer Scientific Steering Committee (GUSC), National Cancer Institute, 2009-2012
Early Detection Cancer Research Network, member 2003-2012
Molecular Diagnostics (Mol Dx), SME 2013 to present
NCI/NIH: Novel Therapeutics for Non-Muscle Invasive Bladder Cancer – Bladder Task Force Clinical Trials Planning Meeting (CTPM) March, 2015

UROLOGY BOARDS
Clarity Pharmaceuticals, Global Medical Advisory Board, 2022-present
Photocure, Inc., Board of Directors, 2022-present
Alessa Therapeutics, Board of Directors, 2022-present
Prostate Cancer UK, Scientific Advisory Board, 2022-present
Maple Tree Alliance, 2021-present
Duke Global Health Initiative (DGHI), 2020-present
Cancer Support Community, 2020-present
Society for Immunotherapy of Cancer (SITC) Prostate Committee, 2018-present
Bladder Cancer Advocacy Network (BCAN), Board of Directors, 2017-present
Society of Urologic Oncology, Executive Board of Directors, 2009-present
Prostate Conditions Education Council, Board of Directors, 2009-present
Urology Times/Modern Medicine Website – www.modernmedicine.com Monthly Blog; Dr. Shore’s Blog, 2008-2010
Medical Director, US Too, Prostate Cancer Support Group, 1999-present
Large Urology Group Practice Association, President, 2016-2018
Society of Urologic Oncology, Clinical Trials Consortium, Secretary Treasurer, 2014-2018
AUA Data Committee, 2012-2018
Large Urology Group Practice Association, Executive Committee Secretary, 2013-2014
South Carolina Urology Executive Committee, Member at Large, 2011-2013
AUA Committee on Male Health, 2009-2012
Society of Urologic Oncology, Clinical Trials Consortium Board of Directors, 2008-2019
Zero – The Project to End Prostate Cancer: National Medical Advisory Board, 2008-2010
Large Urology Group Practice Association, Founding Board Member, Past President, 2005-2021
Large Urology Group Practice Association, Board of Directors, 2005-2020

STEERING COMMITTEE MEMBER
American Urological Association, Innovation Committee, 2022-present
Novartis PSMAfore, 2022-present
US Veterans Association Prostate Cancer Steering Committee, 2021-present
American Urological Association, Research Council, 2021-present
PROTEUS PCR3011 Radical Prostatectomy Trial, 2019-present
Bayer DaroAcT 20609 Castrate Resistant Prostate Cancer Trial, 2019-present
Escalate MCRPC Trial, 2019-present
ORIC-101-02 MCRPC Trial, 2019-present
Modra MCRPC Trial, 2019-present
Merck 3475-676 NMI BC Trial, 2019-present
BMS CA2099UT NMIBC Trial, 2019-present
MerckV397-012 NMIBC Trial, 2019-present
Cold Genesys CG203C NMIBC Trial, 2019-present
International Prostate Forum, Chairman, 2017-present
Bladder and Kidney Cancer Academy, Co-Chair, 2017-present
Prostate Cancer Academy, Co-Chair, 2016-present
Society for Immunotherapy of Cancer, Prostate Cancer Task Force, 2014-present
AstraZeneca/Merck PROpel, 2019-2023
Predict Dendreon Prostate Cancer Registry, 2013-2019
lnnocrin (Viamet) Phase II Trial, 2013-2019
Sequoia E.coli Vaccine Trial, 2013-2019
Metastatic Castrate Resistant Prostate Cancer Registry (Astellas), 2013-2019
Progenics, DSM, 2016-2018
ODM-201-M0 Castrate Resistant Prostate Cancer Trial, 2014-2018

HONORS AND AWARDS
LUGPA Presidential Citation, November 2023 – Awarded in Recognition of Lifetime Achievements in Establishing LUGPA’s
Continuing Medical Education Programs as a Priority in the Organization and
Ensuring that LUGPA’s Programs Remain on the Cutting Edge of Clinical Excellence
Slotkin Lecturer, Northeastern Section of the American Urological Association, 75th Annual Meeting, October 2023 – For the Outstanding Lecture Titled “Current Therapy of Advanced GU Malignancies and Incorporating Clinical Trials into Your Practice”

ADMINISTRATIVE BOARDS
Brookgreen Gardens, President’s Council, 2000-present
Chief of Staff, Grand Strand Regional Medical Center, Myrtle Beach, SC, January 2001 to January 2002
Vice Chief of Staff, Grand Strand Regional Medical Center, Myrtle Beach, SC, January 2000 to January 2001
Secretary/Treasurer Medical Staff, Grand Strand Regional Medical Center, Myrtle Beach, SC, January 1999 to January 2001
Chairman, Department of Surgery, Grand Strand Regional Medical Center, Myrtle Beach, SC, January 1997 to January 1998
Chairman, Carolina Lithotripsy, LLC, Myrtle Beach, SC, January 1997 to January 2004
Medical Advisory Committee, South Strand Ambulatory Care Center, Myrtle Beach, SC, 1997 to 2002
Vice Chairman, Department of Surgery, Grand Strand Regional Medical Center, Myrtle Beach, SC, 1996 to 1997
Big Brothers Horry County, Board of Directors, 1998-1999
Burroughs & Chapin Art Museum, Board of Directors, 2000-2002
Sertoma Club, Board of Directors, President 2000-2001

JOURNAL REVIEWER
Annals of Urology
Asian Journal of Andrology
British Journal of Urology
Canadian Journal of Urology
Cancer Control
Clinical Cancer Research: American Association for Cancer Research
Clinical Genitourinary Cancer
Cochrane Prostatic Diseases and Urologic Cancers Group
Combining Immunotherapy and Radiation for Prostate Cancer
Critical Reviews in Oncology / Hematology
Current Medical Research & Opinion
Cytotherapy: The Journal of Cell Therapy
European Urology
Expert Opinion On Pharmacotherapy
Hospital Practice
International Journal of Molecular Science
Journal of Bone Oncology
Journal of OncoPathology
Journal of Urology
New England Journal Medicine
Oncology
Pharmaceutical Biotechnology
Practice Update
Prostate Cancer
Prostate Cancer and Prostatic Diseases
Prostate Cancer: Incorporating Genomic Biomarkers In Prostate Cancer Decisions
Postgraduate Medicine
Radiation Oncology
Therapeutic Advances in Urology
Urology, The Gold Journal
Urologic Oncology
World Journal of Urology
Yonsei Medical Journal

EDITORIAL BOARDS
Reviews in Urology, Editor in Chief, 2023-present
JU Open Plus, Consulting Editor, 2022-present
Targeted Oncology, Editorial Board, 2021-present
Prostate Cancer Foundation Patient Guide, Editorial Board, 2018-present
World Journal of Urology, 2017-2022
Annals of Hematology & Oncology, 2015
Annals of Urology, 2014-present
Urology Practice, 2014-Present
PLOS One, 2014-2022
Developments in Clinical Oncology, 2014-Present
Urologists in Cancer Care, 2013-Present
Chemotherapy Advisor, 2012-Present
Asian Journal of Andrology, 2012-Present
Current Urology Reports, 2011-Present
OncLive, 2011-Present
Urology Times, 1999-Present

GRANT REVIEWER
California Institute for Regenerative Medicine (CIRM)
National Science Foundation Poland
Swiss National Science Foundation
German Federal Ministry of Education and Research
Prostate UK

ASSOCIATIONS/CERTIFICATIONS
Society of Urologic Oncology, elected 2008
American College of Surgeons Fellow, elected 1993
American Society of Clinical Oncology
American Urological Association
ACRP/APPI, 2005-present
Morley Foundation, Clinical Trials Training for Medical Professionals, 2002-2006
South Carolina Medical Society

CURRENT AND PAST POSITIONS
Carolina Urologic Research Center – Medical Director – 2000-present
Atlantic Urology Specialists, LLC, Myrtle Beach, South Carolina – Clinical Urology Practice – 1994 – present
GenesisCare US – Chief Medical Officer, Surgical Oncology and Urology and Strategic Innovation Chair, Global Prostate Cancer Research – 2019-2024
GenesisCare US – National Urology Research Direction – 2011-2024
Atlantic Urology Clinics – Managing Partner – 2007 – 2012
DASHKO, LLC – Founding Member – 2015 – present
CUSP, LLC – Founding Member – 2011 – present
21st Century Oncology – National Urology Research Director – 2011 – present
Urology Oncology Consortium, LLC – Founding Member – 2008 – 2013
Morristown, New Jersey – Clinical Urology Practice – 1990 – 1994

Treatments Provider Offers

Office Locations

Thank a Doctor

Have you had an exceptional experience with an Atlantic Urology Clinic physician? Let them know!

How Can We Help You?

Language Assistance Services for Individuals With Limited English Proficiency

ATTENTION: If you do not speak English, language assistance services, free of charge, are available to you. Call 843-347-2450.

ATENCIÓN: si habla español, tiene a su disposición servicios gratuitos de asistencia lingüística. Llame al 843-347-2450.

PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa 843-347-2450.

注意:如果您使用繁體中文,您可以免費獲得語言援助服務。請致電 843-347-2450。

CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn.  Gọi số 843-347-2450.

주의:  한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. 843-347-2450. 번으로 전화해 주십시오.

ATANSYON: Si w pale Kreyòl Ayisyen, gen sèvis èd pou lang ki disponib gratis pou ou. Rele 843-347-2450.

ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните 843-347-2450.

ՈՒՇԱԴՐՈՒԹՅՈՒՆ՝  Եթե խոսում եք հայերեն, ապա ձեզ անվճար կարող են տրամադրվել լեզվական աջակցության ծառայություններ:  Զանգահարեք 843-347-2450:

ATTENZIONE: In caso la lingua parlata sia l’italiano, sono disponibili servizi di assistenza linguistica gratuiti. Chiamare il numero 843-347-2450.

فارسیتوجه: اگر به زبان فارسی گفتگو می کنید، تسهیلات زبانی بصورت رایگان برای شما فراهم می باشد. با

843-347-2450

ATENÇÃO: Se fala português, encontram-se disponíveis serviços linguísticos, grátis.  Ligue para 843-347-2450.

ملحوظة:  إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان.  اتصل برقم 1-_843-347-2450_____________ (رقم هاتف الصم والبك).

ध्यान दें:  यदि आप हिंदी बोलते हैं तो आपके लिए मुफ्त में भाषा सहायता सेवाएं उपलब्ध हैं। 843-347-2450 पर कॉल करें।

注意事項:日本語を話される場合、無料の言語支援をご利用いただけます。843-347-2450まで、お電話にてご連絡ください。

ATTENTION: Si vous parlez français, des services d’aide linguistique vous sont proposés gratuitement.  Appelez le 843-347-2450.